Table 1.

Review of the literature on repeated surgery for cholangiocarcinoma

Reference	Year	Patients, n	Primary disease	Survival
				median, months	1-year, %	3-year, %	5-year, %
Yamamoto et al. [14]	2001	4	iCCA	10		29	29
Sotiropoulos et al. [15]	2005	3	iCCa		100	66.6	33.3
Ohtsuka et al. [16]	2009	9	iCCA	22		51.4	51.4
Ercolani et al. [17]	2010	6	iCCA	66.6		60	0
Kamphues et al. [12]	2010	9	iCCA	51		52	29
Song et al. [6]	2011	27	5 iCCa, 9 pCCA, 13 dCCA	18.9
Saiura et al. [18]	2011	5	iCCA			80	60
Sulpice et al. [19]	2012	4	iCCa			100	75
Hyder et l. [20]	2013	33	iCCA	25.8
Zhang et al. [13]	2013	32/77#	iCCA	20.3/21.3#	83.8/69.8c	17.1/20.5c	na
Takahashi et al. [7]	2015	54	7 iCCA, 34 pCCA, 13 dCCA		70	38	18
Noji et al. [21]	2015	18	pCCA/dCCA			25	12
Spolverato et al. [22]	2016	41	iCCA	26.1	na	na	na
Si et al. [23]	2017	72	iCCa	−	97.2	67	41.9
Miyazaki et al. [24]	2017	13	9 iCCA, 3 pCCA, 1 dCCA	28.5		38	19
Bartsch et al. [25]	2019	18	iCCA	39.4	81	55	37
Hu et al. [27]	2019	132 (88*/44**)	iCCA	48.7a/7.6b			11.4a/0b
Yoh et al. [28]	2019	15	iCCA	91.6		86.7
Bartsch et al. [29]	2020	113	iCCA	36.8		51	34

na, not available.

^aR0.

^bR1 or R2.

^cTreated by radiofreqency ablation.